Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMB Study: Varenicline and Bupropion for Alcohol Use Disorder
NCT04167306Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline, bupropion in alcohol use disorder (AUD), sponsored by Region Västra Götaland. Started Mar 2019; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04167306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167306.